Long-Term PSA Outcomes in a Single Institution, Prospective Randomized 131 Cs / 125 I Permanent Prostate Brachytherapy Trial
نویسندگان
چکیده
منابع مشابه
Cesium 131 versus iodine 125 implants for prostate cancer: evaluation of early PSA response.
INTRODUCTION Given the shorter half-life of cesium-131 (Cs-131) compared to iodine-125 (I-125), we hypothesized that initial PSA outcomes may differ. We compare initial PSA outcomes in men undergoing Cs-131 prostate brachytherapy to men treated with I-125. PATIENTS AND METHODS The first post-treatment PSA (obtained 3-6 months after the procedure) was compared in patients undergoing I-125 pros...
متن کاملRe-implantation after insufficient primary 125-i permanent prostate brachytherapy
INTRODUCTION We describe five patients receiving a re-implantation (RI) after post-operative dosimetry of the primary 125-I permanent prostate brachytherapy (BT) for prostate cancer revealed an insufficient dose coverage. MATERIALS AND METHODS Five out of 222 consecutive patients treated (from March, 2001 to August, 2012) with 125-I BT, received a RI after dosimetric verification by CT and MR...
متن کاملPermanent seed brachytherapy for clinically localized prostate cancer: long-term outcomes in a 700 patient cohort.
PURPOSE Few large European studies have evaluated long-term outcomes for permanent prostate brachytherapy (PPB) as monotherapy for clinically localized prostate cancer. The objective of the present study was to evaluate long-term survival in this patient profile. METHODS AND MATERIALS Retrospective study of 700 patients who underwent transperineal ultrasound-guided iodine-125 PPB (145 Gy) bet...
متن کاملIodine-125 seed brachytherapy for early stage prostate cancer: a single-institution review
PURPOSE We are reporting the five-year biochemical control, toxicity profile and dosimetric parameters using iodine-125 low dose rate brachytherapy (BT) as monotherapy for early stage prostate cancer at a single institution. MATERIAL AND METHODS Between April 2006 and December 2010, 169 men with early stage prostate cancer were treated with BT. Biochemical failure was defined using the Phoeni...
متن کاملA Comparison of AUA Symptom Scores following Permanent Low-Dose-Rate Prostate Brachytherapy with Iodine-125 and Cesium-131
Purpose: Transrectal ultrasound (TRUS) is the most common image modality used in permanent prostate brachytherapy (PPI). Although providing excellent prostate visualization, TRUS images are inferior to MRI images for identifying critical structures such as neurovascular bundles (NVB). To preserve erectile function after PPI, the traumatic injury resulting from needles passing through NVB is wor...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International Journal of Radiation Oncology*Biology*Physics
سال: 2017
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2017.06.1212